Mirum Pharmaceuticals (MIRM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $80.14, -2.73% vs the prior close of $82.39.
- Volume 462.92K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MIRM dips 2.7% to $80.14. Closed at $80.14, -2.73% vs the prior close of $82.39. Day range $79.64–$82.48, opened at $82.48.
MIRM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MIRM dips 2.7% to $80.14
- Closed at $80.14, -2.73% vs the prior close of $82.39. Day range $79.64–$82.48, opened at $82.48.
- Volume was 462.92K shares, 0.6x its 50-day average of 763.25K.
- Price is -13.9% vs its 50-day average ($93.05) and -18.7% vs its 200-day average ($98.52).
- 52-week range $63.23–$130.00; today's close sits at 25% of that range, 38.4% below the 52-week high.
Oct 15, 2026 — MIRM jumps 3.0% to $82.39
- Closed at $82.39, +3.04% vs the prior close of $79.96. Day range $81.00–$83.48, opened at $82.10.
- Volume was 605.20K shares, 0.8x its 50-day average of 768.79K.
- Price is -11.7% vs its 50-day average ($93.33) and -16.4% vs its 200-day average ($98.51).
- 52-week range $63.23–$130.00; today's close sits at 29% of that range, 36.6% below the 52-week high.
Oct 14, 2026 — MIRM rises 0.4% to $79.96
- Closed at $79.96, +0.43% vs the prior close of $79.62. Day range $78.35–$81.90, opened at $78.41.
- Volume was 975.10K shares, 1.3x its 50-day average of 761.12K.
- Price is -14.7% vs its 50-day average ($93.79) and -18.8% vs its 200-day average ($98.50).
- 52-week range $63.23–$130.00; today's close sits at 25% of that range, 38.5% below the 52-week high.
Oct 13, 2026 — MIRM slides 7.5% to $79.62
- Closed at $79.62, -7.48% vs the prior close of $86.06. Day range $79.51–$87.00, opened at $86.06.
- Volume was 762.60K shares, 1.0x its 50-day average of 755.87K.
- Price is -15.6% vs its 50-day average ($94.28) and -19.2% vs its 200-day average ($98.50).
- 52-week range $63.23–$130.00; today's close sits at 25% of that range, 38.8% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — MIRM ends flat (+0.1%) to $86.06, 4 up days in a row
- Closed at $86.06, +0.06% vs the prior close of $86.01. Day range $81.95–$88.31, opened at $87.22.
- Volume was 1.21M shares, 1.6x its 50-day average of 743.21K.
- Price is -9.2% vs its 50-day average ($94.78) and -12.6% vs its 200-day average ($98.50).
- 52-week range $63.23–$130.00; today's close sits at 34% of that range, 33.8% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — MIRM jumps 5.7% to $86.01, 3 up days in a row
- Closed at $86.01, +5.73% vs the prior close of $81.35. Day range $81.01–$87.79, opened at $81.01.
- Volume was 1.14M shares, 1.6x its 50-day average of 731.94K.
- Price is -9.6% vs its 50-day average ($95.18) and -12.7% vs its 200-day average ($98.47).
- 52-week range $63.23–$130.00; today's close sits at 34% of that range, 33.8% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — MIRM rises 0.9% to $81.35
- Closed at $81.35, +0.88% vs the prior close of $80.64. Day range $78.63–$82.20, opened at $80.31.
- Volume was 664.30K shares, 0.9x its 50-day average of 732.30K.
- Price is -15.0% vs its 50-day average ($95.71) and -17.4% vs its 200-day average ($98.45).
- 52-week range $63.23–$130.00; today's close sits at 27% of that range, 37.4% below the 52-week high.
Oct 7, 2026 — MIRM rises 1.8% to $80.64
- Closed at $80.64, +1.75% vs the prior close of $79.25. Day range $78.39–$83.13, opened at $78.79.
- Volume was 1.02M shares, 1.4x its 50-day average of 720.64K.
- Price is -16.2% vs its 50-day average ($96.23) and -18.1% vs its 200-day average ($98.43).
- 52-week range $63.23–$130.00; today's close sits at 26% of that range, 38.0% below the 52-week high.
Oct 6, 2026 — MIRM dips 2.7% to $79.25, a 6-month low, 7 down days in a row
- Closed at $79.25, -2.68% vs the prior close of $81.43. Day range $77.78–$81.94, opened at $81.94.
- Volume was 1.15M shares, 1.6x its 50-day average of 706.33K.
- Price is -18.2% vs its 50-day average ($96.87) and -19.4% vs its 200-day average ($98.38).
- 52-week range $63.23–$130.00; today's close sits at 24% of that range, 39.0% below the 52-week high.
- That makes 7 straight losses.
Oct 5, 2026 — MIRM dips 1.8% to $81.43, a 6-month low, 6 down days in a row
- Closed at $81.43, -1.81% vs the prior close of $82.93. Day range $81.23–$83.35, opened at $83.30.
- Volume was 980.10K shares, 1.4x its 50-day average of 697.07K.
- Price is -16.5% vs its 50-day average ($97.57) and -17.2% vs its 200-day average ($98.33).
- 52-week range $63.23–$130.00; today's close sits at 27% of that range, 37.4% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — MIRM dips 1.2% to $82.93, a 6-month low, 5 down days in a row
- Closed at $82.93, -1.18% vs the prior close of $83.92. Day range $81.41–$84.68, opened at $84.67.
- Volume was 1.13M shares, 1.6x its 50-day average of 702.46K.
- Price is -15.5% vs its 50-day average ($98.20) and -15.6% vs its 200-day average ($98.25).
- 52-week range $63.23–$130.00; today's close sits at 30% of that range, 36.2% below the 52-week high.
- That makes 5 straight losses.
MIRM latest news & SEC filings
Every SEC filing by or about MIRM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Peetz Christopher converted options/RSUs into 5,305 shares at $19.19 (≈$101.80K) on Oct 6, 2026; now holds 199,745
- Peetz Christopher converted options/RSUs into 6,892 shares at $15.87 (≈$109.38K) on Oct 6, 2026; now holds 206,637
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 15, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bjerkholt Eric sold 9,943 shares at $98.37 (≈$978.09K) on Sep 14, 2026
- Bjerkholt Eric sold 9,943 shares at $98.37 (≈$978.09K) on Sep 14, 2026
- Bjerkholt Eric sold 9,943 shares at $98.37 (≈$978.09K) on Sep 14, 2026
- Bjerkholt Eric sold 9,943 shares at $98.37 (≈$978.09K) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Howe Jolanda sold 658 shares at $100.00 (≈$65.80K) on Sep 2, 2026
- Howe Jolanda sold 658 shares at $100.00 (≈$65.80K) on Sep 2, 2026
- Howe Jolanda sold 658 shares at $100.00 (≈$65.80K) on Sep 2, 2026
- Howe Jolanda sold 658 shares at $100.00 (≈$65.80K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $176.24M (prior year $127.78M) (+37.9% vs Jun 30, 2025)
- Net income: -$67.23M (prior year -$5.86M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.06 (prior year -$0.12) (loss widened vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade MIRM
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 25, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.90% (largest 7.5%).
- Liquidity: about 859.71K shares (≈$68.90M) trade per day on average.
- 52-week position: $80.14 vs a range of $63.23–$130.00 (25% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Eric Bjerkholt sold 9,943 shares on Sep 14, 2026.
- Latest filings: 8-K Oct 13, 2026; 8-K Sep 28, 2026; 8-K Sep 8, 2026.
- Share count: 64.93M shares outstanding (Jul 31, 2026), +29.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MIRM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 82.48 | 82.48 | 79.64 | 80.14 | 462.92K |
| Oct 15, 2026 | 82.10 | 83.48 | 81.00 | 82.39 | 605.20K |
| Oct 14, 2026 | 78.41 | 81.90 | 78.35 | 79.96 | 975.10K |
| Oct 13, 2026 | 86.06 | 87.00 | 79.51 | 79.62 | 762.60K |
| Oct 12, 2026 | 87.22 | 88.31 | 81.95 | 86.06 | 1.21M |
| Oct 9, 2026 | 81.01 | 87.79 | 81.01 | 86.01 | 1.14M |
| Oct 8, 2026 | 80.31 | 82.20 | 78.63 | 81.35 | 664.30K |
| Oct 7, 2026 | 78.79 | 83.13 | 78.39 | 80.64 | 1.02M |
| Oct 6, 2026 | 81.94 | 81.94 | 77.78 | 79.25 | 1.15M |
| Oct 5, 2026 | 83.30 | 83.35 | 81.23 | 81.43 | 980.10K |
| Oct 2, 2026 | 84.67 | 84.68 | 81.41 | 82.93 | 1.13M |
| Oct 1, 2026 | 85.42 | 86.17 | 83.68 | 83.92 | 641.80K |
| Sep 30, 2026 | 88.85 | 88.85 | 85.36 | 85.48 | 901.20K |
| Sep 29, 2026 | 89.04 | 90.31 | 86.51 | 87.54 | 666.80K |
| Sep 28, 2026 | 90.00 | 91.25 | 84.71 | 87.96 | 1.24M |
| Sep 25, 2026 | 89.90 | 90.81 | 88.28 | 89.70 | 763.60K |
| Sep 24, 2026 | 89.24 | 90.69 | 87.64 | 89.36 | 681.40K |
| Sep 23, 2026 | 91.31 | 91.50 | 87.87 | 89.32 | 739.10K |
| Sep 22, 2026 | 92.49 | 92.82 | 90.55 | 91.39 | 775.20K |
| Sep 21, 2026 | 93.07 | 94.57 | 91.04 | 92.00 | 685.10K |
About Mirum Pharmaceuticals
Mirum Pharmaceuticals (MIRM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FOSTER CITY, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1759425.
MIRM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Laura Brege | Director | Jun 17, 2026 |
| Lon Cardon | Director | Jun 17, 2026 |
| William Fairey | Director | Jun 17, 2026 |
| Laurent Fischer | Director | Jun 17, 2026 |
| Michael G Grey | Director | Jun 17, 2026 |
| Patrick J Heron | Director | Jun 17, 2026 |
| Christopher Peetz | CHIEF EXECUTIVE OFFICER | Sep 3, 2026 |
| Saira Ramasastry | Director | Jun 17, 2026 |
| Timothy P Walbert | Director | Jun 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Sep 15, 2026 |
| Jolanda Howe | SVP, GLOBAL CONTROLLER | Sep 3, 2026 |
| Robert Paul Myers | Chief Medical Officer | Sep 22, 2026 |
| Christopher Peetz | CHIEF EXECUTIVE OFFICER | Sep 3, 2026 |
| Joanne Quan | CHIEF MEDICAL OFFICER | Mar 17, 2026 |
| Peter Radovich | PRESIDENT AND COO | Jun 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Eric Bjerkholt | Sale | 9,943 | $98.37 |
| Sep 14, 2026 | Eric Bjerkholt | Sale | 9,943 | $98.37 |
| Sep 14, 2026 | Eric Bjerkholt | Sale | 9,943 | $98.37 |
| Sep 14, 2026 | Eric Bjerkholt | Sale | 9,943 | $98.37 |
| Sep 2, 2026 | Jolanda Howe | Sale | 658 | $100.00 |
| Sep 2, 2026 | Jolanda Howe | Sale | 658 | $100.00 |
| Sep 2, 2026 | Jolanda Howe | Sale | 658 | $100.00 |
| Sep 2, 2026 | Jolanda Howe | Sale | 658 | $100.00 |
| Sep 1, 2026 | Christopher Peetz | Sale | 8,312 | $98.08 |
| Sep 1, 2026 | Christopher Peetz | Sale | 21,688 | $98.91 |
| Sep 1, 2026 | Christopher Peetz | Sale | 8,312 | $98.08 |
| Sep 1, 2026 | Christopher Peetz | Sale | 21,688 | $98.91 |
| Sep 1, 2026 | Christopher Peetz | Sale | 8,312 | $98.08 |
| Sep 1, 2026 | Christopher Peetz | Sale | 21,688 | $98.91 |
| Sep 1, 2026 | Christopher Peetz | Sale | 8,312 | $98.08 |
MIRM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $521.31M | $-23.36M | -0.47 | $55.83M |
| Dec 31, 2024 | $336.89M | $-87.94M | -1.85 | $10.32M |
| Dec 31, 2023 | $186.37M | $-163.41M | -4.00 | $-70.94M |
| Dec 31, 2022 | $77.06M | $-135.66M | -4.02 | $-120.14M |
| Dec 31, 2021 | $19.14M | $-83.99M | -2.77 | $-132.76M |
Latest balance sheet: total assets $1.04B, total liabilities $1.06B, cash $330.73M (as of Jun 30, 2026).
MIRM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $105.79 |
| May 6, 2026 | 8-K Item 2.02 (results) | $110.08 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $108.62 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $89.50 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $70.97 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $53.39 |
| May 7, 2025 | 8-K Item 2.02 (results) | $41.22 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $50.52 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $44.00 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $42.28 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MIRM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.